Product Name | MF | CAS | Details |
---|
Gallic acid - NSC 674319 | C7H6O5 | 149-91-7 | Details |
Forskolin - Coleonol | C22H34O7 | 66575-29-9 | Details |
Danoprevir - ITMN 191 | RG 7227 | R 7227 | C35H46FN5O9S | 850876-88-9 | Details |
DBeQ | C22H20N4 | 177355-84-9 | Details |
GNE 7915 | C19H21F4N5O3 | 1351761-44-8 | Details |
GSK 2110183 hydrochloride - Afuresertib hydrochloride | C18H18Cl3FN4OS | 1047645-82-8 | Details |
EPZ 015666 - GSK 3235025 | C20H25N5O3 | 1616391-65-1 | Details |
GeA-69 | C20H16N2O | 2143475-98-1 | Details |
CX 4945 hydrochloride - Silmitasertib hydrochloride | Details |
CP 690550 - Tasocitinib | Tofacitinib | C16H20N6O | 477600-75-2 | Details |
DBZ, γ-Secretase Inhibitor | C26H23F2N3O3 | 209984-56-5 | Details |
Daglutril - SLV 306 | C31H38N2O6 | 182821-27-8 | Details |
Fendiline hydrochloride | C23H26ClN | 13636-18-5 | Details |
GDC 0879 | C19H18N4O2 | 905281-76-7 | Details |
Fatostatin hydrobromide - Fatostatin A hydrobromide | 125B11 hydrobromide | C18H19BrN2S | 298197-04-3 | Details |
Genz 644282 | C22H21N3O5 | 529488-28-6 | Details |
Crizotinib, (S)- | C21H22Cl2FN5O | 1374356-45-2 | Details |
EN460 - ERO1 Inhibitor II | C22H12ClF3N2O4 | 496807-64-8 | Details |
DG2 - S6K1 Inhibitor DG2 | C16H17BrN6O | 871340-88-4 | Details |
CYT 387 - Momelotinib | C23H22N6O2 | 1056634-68-4 | Details |
CPTH2 | C14H14ClN3S | 357649-93-5 | Details |
CS1 | C16H12O3 | 1448009-94-6 | Details |
GSK 461364 analogue I | C26H27ClN4O3S | 929095-23-8 | Details |
Daclatasvir dihydrochloride - BMS 790052 dihydrochloride | C40H51ClN8O6 | 1009119-65-6 | Details |
GSK 1120212 - Trametinib | JTP 74057 | C26H23FIN5O4 | 871700-17-3 | Details |
GDC 0980 - RG 7422 | GNE 390 | Apitolisib | C23H30N8O3S | 1032754-93-0 | Details |
FM19G11 | C23H17N3O8 | 329932-55-0 | Details |
DAPT | C23H26F2N2O4 | 208255-80-5 | Details |
Fluconazole - UK 49858 | C13H12F2N6O | 86386-73-4 | Details |
Dimethylenastron - Eg5 inhibitor III | C16H18N2O2S | 863774-58-7 | Details |
Deazaadenosine, 1- | C11H14N4O4 | 14432-09-8 | Details |
Fingolimod - FTY 720 | C19H34ClNO2 | 162359-56-0 | Details |
FQI 1 | C18H17NO4 | 599151-35-6 | Details |
eCF309 | C18H21N7O3 | 2001571-40-8 | Details |
Fluorescent probe QG-1 | C19H21N3O3 | 2098563-70-1 | Details |
FDI 6 - NCGC 00099374 | C19H11F4N3OS2 | 313380-27-7 | Details |
Dasatinib - BMS 354825 | Sprycel | C22H26ClN7O2S | 302962-49-8 | Details |
GNF 2 | C18H13F3N4O2 | 778270-11-4 | Details |
FMK - RSK inhibitor Fmk | C18H19FN4O2 | 821794-92-7 | Details |
DEAB - NSC 8782 | C11H15NO | 120-21-8 | Details |
EBPC | C14H15NO4 | 4450-98-0 | Details |
DC 838 | C27H29N5O4 | 508186-08-1 | Details |
D 106669 | C17H18N6O | 938444-93-0 | Details |
GSK 269962A - GSK 269962 | C29H30N8O5 | 850664-21-0 | Details |
DCC 2036 - Rebastinib | C30H28FN7O3 | 1020172-07-9 | Details |
GSK 2636771 dihydrochloride | C22H22F3N3O3 | 1372540-25-4 | Details |
DiMNF | C21H16O4 | 14756-24-2 | Details |
CRT0066854 | C24H25N5S | 1438881-19-6 | Details |
GSK 2982772 | C20H19N5O3 | 1622848-92-3 | Details |
Dansyl-PEG-phenylboronic acid | Details |
Exemestane - Aromasin | FCE 24304 | C20H24O2 | 107868-30-4 | Details |
CP 316819 | C21H22ClN3O4 | 186392-43-8 | Details |
Geranyl pyrophosphate ammonium salt - GPP | C10H23NO7P2 | 116057-55-7 | Details |
CP 471474 | C16H17FN2O5S | 210755-45-6 | Details |
Donepezil hydrochloride | C24H30ClNO3 | 120011-70-3 | Details |
FK 866 hydrochloride - K 22.175 hydrochloride | C24H29N3O2 | 658084-64-1 | Details |
GSK 461364 | C27H28F3N5O2S | 929095-18-1 | Details |
Gisadenafil besylate - UK 369003 | PF 01224715 | C29H39N7O8S2 | 334827-98-4 | Details |
Dolutegravir - GSK 1349572 | Soltegravir | Tivicay | C20H19F2N3O5 | 1051375-16-6 | Details |
CX 5461 | C27H27N7O2S | 1138549-36-6 | Details |
GSK 2606414 | C24H20F3N5O | 1337531-36-8 | Details |
FG-2216 - YM 311 | C12H9ClN2O4 | 223387-75-5 | Details |
CP 31398 | C22H26N4O | 1217195-61-3 | Details |
CX 6258 hydrochloride | C26H25Cl2N3O3 | 1353859-00-3 | Details |
CTx-0294885 | C22H24ClN7O | 1439934-41-4 | Details |
Decitabine | C8H12N4O4 | 2353-33-5 | Details |
CPI 4203 | C16H14N4O | 1628214-07-2 | Details |
Digoxigenin bisdigitoxoside | C35H54O11 | 5297-05-2 | Details |
cPEPCK inhibitor | C25H26FN5O3 | 628279-07-2 | Details |
Eeyarestatin I - ES1 | ERAD inhibitor 1 | p97 inhibitor 1 | C27H25Cl2N7O7 | 412960-54-4 | Details |
GANT61 - NSC 136476 | C27H35N5 | 500579-04-4 | Details |
FR 180204 | C18H13N7 | 865362-74-9 | Details |
CZC 24832 | C15H17FN6O2S | 1159824-67-5 | Details |
GSK 126 | C31H38N6O2 | 1346574-57-9 | Details |
Dorzolamide hydrochloride | C10H16N2O4S3.ClH | 130693-82-2 | Details |
GSK 461364 analogue II | C27H27F3N4O3S | 929095-22-7 | Details |
COTI-2 | C19H22N6S | 1039455-84-9 | Details |
G 6983 - GO 6983 | Goe 6983 | C26H26N4O3 | 133053-19-7 | Details |
EVP 4593 | C22H20N4O | 545380-34-5 | Details |
Dapivirine - R 147681 | TMC 120 | C20H19N5 | 244767-67-7 | Details |
DMOG | C6H9NO5 | 89464-63-1 | Details |
GDC 0941 bismesylate - Pictilisib | C24H30N7O6S3 | 957054-33-0 | Details |
FG-4592 - Roxadustat | ASP 1517 | C19H16N2O5 | 808118-40-3 | Details |
FIPI hydrochloride | C23H24FN5O2 | 939055-18-2 | Details |
EHop 016 | C25H30N6O | 1380432-32-5 | Details |
EPZ 6438 - Tazemetostat | C34H44N4O4 | 1403254-99-8 | Details |
FRAX 486 | C25H23Cl2FN6O | 1232030-35-1 | Details |
Defactinib - VS 6063 | PF 04554878 | C20H21F3N8O3S | 1073154-85-4 | Details |
Delavirdine - U 90152 | Rescriptor | C22H28N6O3S | 136817-59-9 | Details |
GSK 2256294A - GSK 2256294 | C21H24F3N7O | 1142090-23-0 | Details |
CPI 455 | C16H14N4O | 1628208-23-0 | Details |
EML 425 | C27H24N2O4 | 1675821-32-5 | Details |
Enzastaurin - LY 317615 | C32H29N5O2 | 170364-57-5 | Details |
GSK 2126458 - Omipalisib | C25H17F2N5O3S | 1086062-66-9 | Details |
CP 466722 | C17H15N7O2 | 1080622-86-1 | Details |
GSK 2578215A | C24H18FN3O2 | 1285515-21-0 | Details |
GNE 317 | C19H22N6O3S | 1394076-92-6 | Details |
EED226 | C17H15N5O3S | 2083627-02-3 | Details |
Deguelin | C23H22O6 | 522-17-8 | Details |
DR 2313 | C8H10N2OS | 284028-90-6 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 |